
@Article{biocell.2020.010018,
AUTHOR = {WENJUAN LI, GE SONG},
TITLE = {Updated thoughts on SARS-CoV-2 and coronavirus therapies, fighting and surviving},
JOURNAL = {BIOCELL},
VOLUME = {44},
YEAR = {2020},
NUMBER = {2},
PAGES = {127--135},
URL = {http://www.techscience.com/biocell/v44n2/39263},
ISSN = {1667-5746},
ABSTRACT = {From late December 2019 a new human-adapted coronavirus, SARS-CoV-2, was observed and isolated in
clustered patients in Wuhan, China. It has been proved to be able to transmit human-to-human and cause
pneumonia, leading to about 2% fatality. Its genome characteristics, immune responses and related potential
treatments, such as chemical drugs, serum transfusion and vaccines including DNA vaccines, are discussed in this
review for a brief summary.},
DOI = {10.32604/biocell.2020.010018}
}



